Rachel’s London Marathon 2024 fundraiser for The Institute of Cancer Research (ICR)
Help Rachel Talbot raise money to support The Institute of Cancer Research (ICR)
Help Rachel Talbot raise money to support The Institute of Cancer Research (ICR)
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve…
The International Journal of Cancer is a cancer journal from the Union for International Cancer Control covering experimental and clinical cancer research.
First-line atezolizumab plus sacituzumab govitecan led to responses in PD-L1–positive locally advanced or metastatic triple-negative breast cancer.
Samilia Obeng-Gyasi, MD, MPH, highlights a study on the association between neighborhood opportunity with all-cause mortality in patients with breast cancer.
Capivasertib plus fulvestrant improved time to second progression in patients with pretreated HR-positive, HER2-negative advanced breast cancer.
In the first article of a 2-part series, Virginia G. Kaklamani, MD, discussed her approach to biomarker testing and treatment sequencing for patients with hormone…
Trastuzumab deruxtecan demonstrated superior long-term survival and response rates vs treatment of physician’s choice in HER2-positive breast cancer.
Researchers sought to measure the awareness of and openness to receive BCMA-targeted therapies among patients with multiple myeloma.
Radiation therapy is a critical component of cancer care that is currently being used in approximately 50% of all patients with cancer.
Nini Wu, MD, MBA, highlights practical technology in community oncology and how it is used to enhance patient and staff experiences.